Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Correction: Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.

Xie E, Kotha A, Biaco T, Sedani N, Zou J, Stashenko P, Duncan MJ, Campos-Neto A, Cayabyab MJ.

PLoS One. 2016 Jan 22;11(1):e0147781. doi: 10.1371/journal.pone.0147781. eCollection 2016. No abstract available.

2.

Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.

Xie E, Kotha A, Biaco T, Sedani N, Zou J, Stashenko P, Duncan MJ, Campos-Neto A, Cayabyab MJ.

PLoS One. 2015 Nov 30;10(11):e0143422. doi: 10.1371/journal.pone.0143422. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0147781.

3.

Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination.

Daifalla N, Cayabyab MJ, Xie E, Kim HB, Tzipori S, Stashenko P, Duncan M, Campos-Neto A.

Microbes Infect. 2015 Mar;17(3):237-42. doi: 10.1016/j.micinf.2014.11.002. Epub 2014 Dec 15.

4.

An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.

Cayabyab MJ, Qin L, Kashino SS, Izzo A, Campos-Neto A.

Vaccine. 2013 Oct 1;31(42):4834-40. doi: 10.1016/j.vaccine.2013.07.077. Epub 2013 Aug 9.

5.

Current and novel approaches to vaccine development against tuberculosis.

Cayabyab MJ, Macovei L, Campos-Neto A.

Front Cell Infect Microbiol. 2012 Dec 6;2:154. doi: 10.3389/fcimb.2012.00154. eCollection 2012. Review.

6.

Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol.

Cayabyab MJ, Kashino SS, Campos-Neto A.

Immunology. 2012 Mar;135(3):216-25. doi: 10.1111/j.1365-2567.2011.03525.x.

7.

Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.

Cayabyab MJ, Korioth-Schmitz B, Sun Y, Carville A, Balachandran H, Miura A, Carlson KR, Buzby AP, Haynes BF, Jacobs WR, Letvin NL.

J Virol. 2009 Jun;83(11):5505-13. doi: 10.1128/JVI.02544-08. Epub 2009 Mar 18.

8.

Duration of antigen expression in vivo following DNA immunization modifies the magnitude, contraction, and secondary responses of CD8+ T lymphocytes.

Hovav AH, Panas MW, Rahman S, Sircar P, Gillard G, Cayabyab MJ, Letvin NL.

J Immunol. 2007 Nov 15;179(10):6725-33.

9.

The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells.

Hovav AH, Panas MW, Osuna CE, Cayabyab MJ, Autissier P, Letvin NL.

J Virol. 2007 Dec;81(23):12793-802. Epub 2007 Sep 19.

10.

Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.

Qin L, Greenland JR, Moriya C, Cayabyab MJ, Letvin NL.

J Virol. 2007 Oct;81(19):10606-13. Epub 2007 Jul 25.

11.

Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.

Hovav AH, Cayabyab MJ, Panas MW, Santra S, Greenland J, Geiben R, Haynes BF, Jacobs WR Jr, Letvin NL.

J Virol. 2007 Jan;81(1):74-83. Epub 2006 Oct 18.

12.

Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.

Yu JS, Peacock JW, Vanleeuwen S, Hsu T, Jacobs WR Jr, Cayabyab MJ, Letvin NL, Frothingham R, Staats HF, Liao HX, Haynes BF.

Clin Vaccine Immunol. 2006 Nov;13(11):1204-11. Epub 2006 Aug 30.

13.

Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.

Cayabyab MJ, Hovav AH, Hsu T, Krivulka GR, Lifton MA, Gorgone DA, Fennelly GJ, Haynes BF, Jacobs WR Jr, Letvin NL.

J Virol. 2006 Feb;80(4):1645-52.

Supplemental Content

Loading ...
Support Center